[HTML][HTML] Polyethylenimine (PEI) in gene therapy: Current status and clinical applications

J Casper, SH Schenk, E Parhizkar, P Detampel… - Journal of Controlled …, 2023 - Elsevier
Polyethlyenimine (PEI) was introduced 1995 as a cationic polymer for nucleic acid delivery.
PEI and its derivatives are extensively used in basic research and as reference formulations …

Haemophilias a and b

PHB Bolton-Maggs, KJ Pasi - The lancet, 2003 - thelancet.com
The haemophilias are inherited disorders in which one of the coagulation factors is deficient.
Although deficiencies of factor VIII (haemophilia A) and factor IX (haemophilia B) are well …

Nonviral gene therapy: promises and challenges

S Li, L Huang - Gene therapy, 2000 - nature.com
The last 10 years have seen substantial progress in the development and application of
nonviral vectors in gene therapy. However, many problems remain to be resolved before …

PFK-2/FBPase-2: maker and breaker of the essential biofactor fructose-2, 6-bisphosphate

DA Okar, AJ Lange, À Manzano… - Trends in biochemical …, 2001 - cell.com
Abstract Fructose-2, 6-bisphosphate is responsible for mediating glucagon-stimulated
gluconeogenesis in the liver. This discovery has led to the realization that this compound …

Cationic lipids and polymers mediated vectors for delivery of siRNA

S Zhang, B Zhao, H Jiang, B Wang, B Ma - Journal of Controlled Release, 2007 - Elsevier
RNA interference (RNAi) is one of the most importantly protective phenomena forming from
the process combating against virus. Since its high efficiency for silencing the expression of …

Genetic lesions of bilirubin uridine‐diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler‐Najjar and Gilbert syndromes: correlation of genotype …

A Kadakol, SS Ghosh, BS Sappal, G Sharma… - Human …, 2000 - Wiley Online Library
Uridine‐diphosphoglucuronate glucuronosyltransferases (UGTs) are a family of enzymes
that conjugate various endogenous and exogenous compounds with glucuronic acid and …

Gene transfer into genomes of human cells by the sleeping beauty transposon system

AM Geurts, Y Yang, KJ Clark, G Liu, Z Cui, AJ Dupuy… - Molecular Therapy, 2003 - cell.com
Abstract The Sleeping Beauty (SB) transposon system, derived from teleost fish sequences,
is extremely effective at delivering DNA to vertebrate genomes, including those of humans …

Molecular mechanism of phase I and phase II drug‐metabolizing enzymes: implications for detoxification

T Iyanagi - International review of cytology, 2007 - Elsevier
Enzymes that catalyze the biotransformation of drugs and xenobiotics are generally referred
to as drug‐metabolizing e nzymes (DMEs). DMEs can be classified into two main groups …

Glucuronidation and the UDP-glucuronosyltransferases in health and disease

PG Wells, PI Mackenzie, JR Chowdhury… - Drug metabolism and …, 2004 - ASPET
This article is an updated report of a symposium held at the June 2000 annual meeting of
the American Society for Pharmacology and Experimental Therapeutics in Boston. The …

[PDF][PDF] Targeting hepatocytes for drug and gene delivery: emerging novel approaches and applications

J Wu, MH Nantz, MA Zern - Front Biosci, 2002 - article.imrpress.com
Introduction 3. Asialoglycoprotein receptor 3.1. Biology of asialoglycoprotein receptor (ASGP-
R) 3.2. Carbohydrate recognition domain (CRD) 3.3 Internalization of the ligands by ASGP …